Shepherd Kaplan Krochuck and Molex Ventures have helped the epinephrine pen developer raise $12.1m of a funding round expected to close at $39m.

Molex Ventures, a subsidiary of manufacturing, chemicals and energy conglomerate Koch Industries, has invested in US-based pharmaceutical device developer Windgap Medical, in a round sized at $12.1m according to a regulatory filing. The company said the round is being led by financial services provider Shepherd Kaplan Krochuck, and it has targeted a $39m close according…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.